The future of gene sequencing in cancer looks promising, with ongoing advancements in sequencing technologies and bioinformatics. Innovations such as single-cell sequencing, liquid biopsies, and artificial intelligence are expected to further enhance the precision and accessibility of cancer diagnosis and treatment. These advancements will continue to drive the development of more effective, personalized cancer therapies.
